Long-Term Follow-up of Patients with Corticosteroid-Refractory Graft-Versus-Host Disease Treated with Ruxolitinib

被引：8
|
作者：
Zeiser, Robert
Burchert, Andreas
Lengerke, Claudia
Verbeek, Mareike
Maas-Bauer, Kristina
Metzelder, Stephan
Spoerl, Silvia
Ditschkowski, Markus
Ecsedi, Matyas
Sockel, Katja
Ayuk, Francis
Salem, Ajib
de Fontbrune, Flore Sicre
Na, Il-Kang
Livius, Penter
Holtick, Udo
Wolf, Dominik
Schuler, Esther
Meyer, Everett
Apostolova, Petya
Bertz, Hartmut
Marks, Reinhard
Lubbert, Michael
Wasch, Ralph
Scheid, Christof
Stolzel, Friedrich
Ordemann, Rainer
Bug, Gesine
Kobbe, Guido
Shah, Omid
Negrin, Robert S.
Brune, Mats
Spyridonidis, Alexandros
Schmitt-Graeff, Annette
van der Velden, Walter J. F. M.
Huls, Gerwin
Mielke, Stephan
Grigoleit, Goetz Ulrich
Kuball, Jurgen
Flynn, Ryan P.
Ihorst, Gabriele
Du, Jing
Blazar, Bruce R.
Arnold, Renate
Kroger, Nicolaus
Passweg, Jakob R.
Halter, Joerg
Socie, Gerard
Beelen, Dietrich W.
Peschel, Christian
机构：
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.4561.4561
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4561
引用
收藏
页数：4
相关论文
共 50 条
  • [31] ROCK1/2 signaling contributes to corticosteroid-refractory acute graft-versus-host disease
    Kristina Maas-Bauer
    Anna-Verena Stell
    Kai-Li Yan
    Enrique de Vega
    Janaki Manoja Vinnakota
    Susanne Unger
    Nicolas Núñez
    Johana Norona
    Nana Talvard-Balland
    Stefanie Koßmann
    Carsten Schwan
    Cornelius Miething
    Uta S. Martens
    Khalid Shoumariyeh
    Rosa P. Nestor
    Sandra Duquesne
    Kathrin Hanke
    Michal Rackiewicz
    Zehan Hu
    Nadia El Khawanky
    Sanaz Taromi
    Hana Andrlova
    Hemin Faraidun
    Stefanie Walter
    Dietmar Pfeifer
    Marie Follo
    Johannes Waldschmidt
    Wolfgang Melchinger
    Michael Rassner
    Claudia Wehr
    Annette Schmitt-Graeff
    Sebastian Halbach
    James Liao
    Georg Häcker
    Tilman Brummer
    Joern Dengjel
    Geoffroy Andrieux
    Robert Grosse
    Sonia Tugues
    Bruce R. Blazar
    Burkhard Becher
    Melanie Boerries
    Robert Zeiser
    Nature Communications, 15
  • [32] Long-term follow-up of rituximab in treatment of chronic graft-versus-host disease-single center experience
    Klobuch, Sebastian
    Weber, Daniela
    Holler, Barbara
    Edinger, Matthias
    Herr, Wolfgang
    Holler, Ernst
    Wolff, Daniel
    ANNALS OF HEMATOLOGY, 2019, 98 (10) : 2399 - 2405
  • [33] Long-term survival follow-up and factors associated to response and survival of patients treated with daclizumab for steroid-resistant acute graft-versus-host disease
    Yafour, N.
    Deville, L.
    Maillard, N.
    Durier, C.
    Montagnier, D.
    Ouachee-Chardin, M.
    Singlas, E.
    Buzyn, A.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S116 - S116
  • [34] Daclizumab for children with corticosteroid refractory graft-versus-host disease
    D T Teachey
    B Bickert
    N Bunin
    Bone Marrow Transplantation, 2006, 37 : 95 - 99
  • [35] Daclizumab for children with corticosteroid refractory graft-versus-host disease
    Teachey, DT
    Bickert, B
    Bunin, N
    BONE MARROW TRANSPLANTATION, 2006, 37 (01) : 95 - 99
  • [36] Ruxolitinib for steroid-refractory acute graft-versus-host disease
    Toama, Wael
    Fiala, Mark
    Pusic, Iskra
    Westervelt, Peter
    Dipersio, John F.
    Schroeder, Mark
    TRANSPLANT INTERNATIONAL, 2020, 33 (02) : 244 - 246
  • [37] Cyclosporine and methotrexate with or without methylprednisolone in the prophylaxis of graft-versus-host disease: Long-term follow-up of a randomized study.
    Ruutu, T
    Volin, L
    Parkkali, T
    Juvonen, E
    Elonen, E
    BLOOD, 1998, 92 (10) : 685A - 685A
  • [38] Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease
    Zeiser, Robert
    Polverelli, Nicola
    Ram, Ron
    Hashmi, Shahrukh K.
    Chakraverty, Ronjon
    Middeke, Jan Moritz
    Musso, Maurizio
    Giebel, Sebastian
    Uzay, Ant
    Langmuir, Peter
    Hollaender, Norbert
    Gowda, Maanasa
    Stefanelli, Tommaso
    Lee, Stephanie J.
    Teshima, Takanori
    Locatelli, Franco
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (03): : 228 - 238
  • [39] Ruxolitinib treatment for steroid-refractory graft-versus-host disease
    Park, Han-Seung
    Lee, Je-Hwan
    Lee, Jung-Hee
    Choi, Eun-Ji
    Seol, Miee
    Lee, Young-Shin
    Kang, Young-Ah
    Jeon, Mijin
    Lee, Kyoo-Hyung
    BONE MARROW TRANSPLANTATION, 2019, 54 : 323 - 324
  • [40] Long-Term Follow-Up of Patients With Dry Eye Associated With Chronic Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplantation
    Sales, C. S.
    Johnston, L. J.
    Ta, C. N.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
12345